CBO Rustagi said with India implementing the second phase of its approved-models list for cells, "approximately 75% of the demand is going to be served by domestically made cells."
Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.